In case you missed it: Feb. 21 to Feb. 25

Check out the week’s top stories.

HHS awards nearly $55 million to increase access to underserved populations

Twenty-nine HRSA-funded health centers to receive a boost in technology to improve outcomes.

Read more

AUGS executive summary: Postoperative opioid prescribing after female pelvic medicine and reconstructive surgery

The American Urogynecologic Society (AUGS) published an executive summary on postoperative opioid prescribing after female pelvic medicine and reconstructive surgery.

Read more

Identifying the optimal gestational weight gain for infant health

Gone are the days of little guidance for weight gain during pregnancy, but determining the best weight range has been elusive. A new study provides some helpful advice.

Read more

Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents

Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.

Learn more

What physicians need to know about the civil rights complaint process

Don’t dread a call from OCR investigators. They are here to help physicians and other providers avoid astronomical monetary penalties.

Read more